How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Cell Isolation or Cell Separation Market
- By Technology: Magnetic-Activated Cell Sorting (MACS), Fluorescence-Activated Cell Sorting (FACS), Density Gradient Centrifugation, Microfluidics-Based Cell Sorting, Immunoaffinity Cell Separation
- By Product Type: Instruments, Reagents and Consumables, Software and Services
- By Application: Stem Cell Research, Cancer Research, Immunology, Drug Discovery and Development, Clinical Diagnostics
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Diagnostic Laboratories, Contract Research Organizations (CROs)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Magnetic-Activated Cell Sorting (MACS) leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.165 →
- 11 Company Profiles 14 players: SWOT & benchmarking p.173 →
Full report · locked preview
Everything inside the Cell Isolation or Cell Separation Market report
A complete, evidence-based study - 11 chapters and 114 sections covering market size, segmentation across 4 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Product Type 3
Application 5
End User 4
Companies profiled
Thermo Fisher Scientific
Miltenyi Biotec
BD Biosciences
STEMCELL Technologies
Bio-Rad Laboratories
Cytiva (part of Danaher)
Beckman Coulter Life Sciences
Sartorius AG
Sony Biotechnology
Partec GmbH
Sysmex Corporation
Union Biometrica
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Miltenyi Biotec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BD Biosciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →STEMCELL Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cytiva (part of Danaher)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Beckman Coulter Life Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sartorius AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sony Biotechnology
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Partec GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Sysmex Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Union Biometrica
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Cell Microsystems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nexcelom Bioscience
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,130M by 2033 · 6.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Magnetic-Activated Cell Sorting (MACS)38.4
- Fluorescence-Activated Cell Sorting (FACS)17.1
- Density Gradient Centrifugation13.9
- Microfluidics-Based Cell Sorting14.3
- Immunoaffinity Cell Separation16.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$434.6M → $709.4M · 6.3%
Europe$302.9M → $477.4M · 5.9%
Asia Pacific$276.6M → $471.2M · 6.9%
Latin America$171.2M → $268.5M · 5.8%
Middle East and Africa$131.7M → $190.8M · 4.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.152026
6.162027
6.162028
6.172029
6.192030
6.212031
6.222032
6.232033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific15.2
- Miltenyi Biotec12.5
- BD Biosciences11.7
- STEMCELL Technologies11.4
- Bio-Rad Laboratories7.6
- Cytiva (part of Danaher)13.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology29.8%
Product Type31.8%
Application10.8%
End User27.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe22.5
- Asia Pacific22.3
- Latin America12.7
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 84 | 97 | 90 | 76 | 98 | 90 | 89 |
| Miltenyi Biotec | 82 | 69 | 87 | 79 | 78 | 91 | 81 |
| BD Biosciences | 70 | 83 | 71 | 67 | 80 | 72 | 74 |
| STEMCELL Technologies | 59 | 65 | 77 | 74 | 61 | 61 | 66 |
| Bio-Rad Laboratories | 60 | 66 | 53 | 75 | 66 | 54 | 62 |
| Cytiva (part of Danaher) | 46 | 60 | 57 | 52 | 70 | 57 | 57 |
| Beckman Coulter Life Sciences | 65 | 53 | 57 | 58 | 51 | 45 | 55 |
| Sartorius AG | 55 | 42 | 59 | 51 | 38 | 35 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Miltenyi Biotec
- BD Biosciences
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Miltenyi Biotec | ◐ | ◐ | ✓ | ◐ | ✓ | ✓ |
| BD Biosciences | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| STEMCELL Technologies | − | ◐ | ◐ | ◐ | − | ◐ |
| Bio-Rad Laboratories | ◐ | − | ◐ | ◐ | ◐ | − |
| Cytiva (part of Danaher) | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Beckman Coulter Life Sciences | ◐ | ◐ | ◐ | − | ◐ | − |
| Sartorius AG | − | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific89
2Miltenyi Biotec81
3BD Biosciences74
4STEMCELL Technologies66
5Bio-Rad Laboratories62
6Cytiva (part of Danaher)57
7Beckman Coulter Life Sciences55
8Sartorius AG47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificMiltenyi Biotec
Challenger1
Strong scale, closing on the leaders.
BD Biosciences
Contender3
Focused players with pockets of strength.
STEMCELL TechnologiesBio-Rad LaboratoriesCytiva (part of Danaher)
Niche2
Specialists in a single segment or region.
Beckman Coulter Life SciencesSartorius AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology in North America, then scale across Cell Isolation or Cell Separation Market — a $529M beachhead inside a $8.36B market.
Beachhead (SOM)$529Mobtainable near-term
Serviceable (SAM)$3.03Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Magnetic-Activated Cell Sorting (MACS)
Best fit — highest urgency & budget in Technology.
Economic buyer75 fit
Fluorescence-Activated Cell Sorting (FACS)
Strong fit — clear ROI and a fast path to value.
End user67 fit
Density Gradient Centrifugation
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Cell Isolation or Cell Separation Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified25%
Evaluation11%
Closed-won6%
$10.9KCAC
$53KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Cell Isolation or Cell Separation Market is a resilient opportunity — $5.39B by 2033, compounding at 3.5%.
TAM · 2025$4.10Btoday
TAM · 2033$5.39Bforecast
CAGR3.5%2027–2033
Cumulative$42.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.39BTotal addressable market
SAM$2.02BServiceable available market
SOM$416MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.5% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.39BLarge & growingTAM by 2033 at 3.5% CAGR
$2.02BServiceable nowreachable with today’s model
$416MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.21BBear2.3% CAGR
$5.39BBase3.5% CAGR
$6.90BBull4.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Cell Isolation or Cell Separation Market — a $10.6B market by 2033. Plan: grow share from 6.8% to 12.6%.
Market size · 2033$10.6Btotal addressable
Market CAGR11.3%2027–2033
Target share12.6%from 6.8% today
Revenue ambition$1.34Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.8% | 12.6% | Ahead |
| Revenue | $762M | $1.34B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 36.1% | 45.8% | On track |
| Customer retention | 89.7% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Type capability
A defensible second engine — invest in Product Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $155M capacity & capability investment
- Greenlight bolt-on M&A in Product Type
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Cell Isolation or Cell Separation Market conversation — a $6.35B market you can size, segment and defend in minutes.
Market size · 2033$6.35Btotal opportunity
Growth3.9%CAGR to 2033
Addressable buyers1,561+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 2 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Thermo Fisher ScientificMiltenyi BiotecBD BiosciencesSTEMCELL TechnologiesBio-Rad LaboratoriesCytiva (part of Danaher)Beckman Coulter Life SciencesSartorius AG+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Cell Isolation or Cell Separation Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Cell Isolation or Cell Separation Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Cell Leukodystrophy (Krabbe Disease) Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportCell Line and Identification Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportCell Line Toxicology Instruments Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportCell Lines Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportCell Phone Cellular Repeater Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportCell Phone Charger Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportCell Phone Repeaters Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportCell Phone Screen Protector Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportCell Phone Signal Shielding Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportCell Phone Tripod Adaptor Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportCell Phone Tripod Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportCell Phone Windshield Mount Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.